Fig. 5
Plot summarizing the distribution of the average number of intravitreal (IV) injections of ranibizumab for the management of diabetic macular edema up to week 52
Fig. 5 | International Journal of Retina and Vitreous
Plot summarizing the distribution of the average number of intravitreal (IV) injections of ranibizumab for the management of diabetic macular edema up to week 52